---
title: "Primary Regimens of Neutropenia-Febrile-High-Risk"
date: "2023-02-07"
enableToc: false
---

> [!info] 
> 
> ðŸŒ±ä¾†è‡ª: [[Neutropenia-Febrile-High-Risk]]

# Primary Regimens of Neutropenia-Febrile-High-Risk

*   **Initial therapy for fever:**

*   [Cefepime][6] 2 gm IV q8h OR an anti-pseudomonal carbapenem [(Meropenem][7] 1-2 gm IV q8h or [Imipenem][8] 500 IV q6h or [Doripenem][9] 500 mg IV q8h)
*   *For enhanced gram+ coverage* (suspected central line associated blood stream infection, severe mucositis, skin and soft tissue infection, pneumonia, or hemodynamic instability): [Vancomycin][10] 15-20 mg/kg IV q8-12h
*   *If hemodynamic instability is present:* Consider addition of [(Tobramycin][11] 5.1 mg/kg IV q24h + [Vancomycin][12] 15-20 mg/kg IV q8-12h + [Echinocandin][13])(see below)
*   See Comments for duration of therapy

*   **Continued fever, no source identified, day 2-4 empiric therapy**

*   Clinically stable: continue work-up for infection sites, consider chest and sinus CT, symptom based imaging, fungal serology

*   **Continued fever, no source identified, day 4-7 empiric therapy**

*   Continue work-up for infection sites
*   No anti-candidal prophylaxis: Consider addition ofÂ [Caspofungin][14] 70 mg IV day 1 and then 50 mg IV q24h or [Micafungin][15] 100 mg IV q24h or [Anidulafungin][16] 200 mg IV x 1 dose and then 100 mg IV q24h
*   On anti-candidal prophylaxis: Consider addition of [Voriconazole][17] 6 mg/kg IV/po q12h x 2 doses, then 4 mg/kg IV/po q12h

